Ottawa Hospital Research Institute, United Therapeutics disclose MSCs overexpressing AOAH May 29, 2020
Kallikrein-6 as novel pharmacological target to promote remyelination in multiple sclerosis May 29, 2020
SAB Biotherapeutics plans to initiate clinical testing of potential COVID-19 therapeutic May 29, 2020
resTORbio initiates study of RTB-101 as antiviral prophylaxis to reduce severity of COVID-19 May 29, 2020
RSS